Published: 10 February 2020

Committees

SUMMARY OF RECOMMENDATIONS FROM THE 109TH MEETING OF THE MEDICINES ASSESSMENT ADVISORY COMMITTEE HELD IN WELLINGTON ON TUESDAY 2 february 2021 AT 9:30 AM

4.

Applications for consent to distribute a new medicine under section 23 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2))

4.1

Comirnaty (COVID-19 mRNA vaccine), 0.5 mg/mL (TT50-10853)
Pfizer New Zealand Limited

The Committee recommended that the Minister of Health should grant provisional consent to distribute this medicine under Section 23 of the Medicines Act 1981 and impose the conditions proposed by Medsafe as amended by the Committee. The Committee recommended that the provisional consent should have an effect of nine months.
Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /